Oxygen evolution reaction catalysis

US2018305831A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018305831-A1
Application numberUS-201815957769-A
CountryUS
Kind codeA1
Filing dateApr 19, 2018
Priority dateApr 19, 2017
Publication dateOct 25, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An oxygen evolution reaction catalyst is a ternary metal oxide that includes Mn and is represented by Mn u Sb v O w in the rutile crystal phase and M x Mn y O z where M is selected from the group consisting of Ca, Ni, Sr, Zn, Mg, Ni, Ba, Co and where u/(u+v) is greater than 33%.

First claim

Opening claim text (preview).

1 . A composition of matter, comprising: Mn, Sb, and oxygen arranged in a rutile crystal phase that includes more Mn than Sb. 2 . The composition of matter of claim 1 , wherein the rutile crystal phase consists of the Mn, the Sb, and the oxygen. 3 . The composition of matter of claim 1 , wherein the composition is represented by Mn u Sb v O w where v is greater than w and w is greater than 0.0. 4 . The composition of matter of claim 3 , wherein u/(u+v) is greater than 50% and less than or equal to 70%. 5 . An electro-oxidation system, comprising: an oxidation catalyst that includes Mn u Sb v O w in the rutile crystal phase where u/(u+v) is greater than 33% and w is greater than 0.0. 6 . The system of claim 5 , wherein u/(u+v) is greater than 55%. 7 . The system of claim 6 , wherein u/(u+v) is greater than 55% and less than or equal to 70%. 8 . The system of claim 5 , wherein the catalyst is included in an anode. 9 . The system of claim 8 , wherein the anode includes a catalytic layer on a current collector and the catalytic layer includes the catalyst. 10 . The system of claim 9 , wherein the current collector is photoactive. 11 . The system of claim 9 , wherein the anode contacts an anolyte having a pH less than 3. 12 . The system of claim 11 , wherein the Mn u Sb v O w catalyzes oxygen evolution. 13 . An electro-oxidation system, comprising: an anode that includes one or more components represented by M x Mn y O z where x, y, and z are each greater than 0.0; M is selected from the group consisting of Ca, Ni, Sr, Zn, Mg, Ni, Ba, Co; and when M is Ca then 0.45≤x/(x+y)≤0.55 and 1.35≤z/(x+y)≤1.65, or 0.36≤x/(x+y)≤0.44 and 1.44≤z/(x+y)≤1.76; and when M is Ni then 0.45≤x/(x+y)≤0.55 and 1.35≤z/(x+y)≤1.65, or 0.77≤x/(x+y)≤0.99 and 1.03≤z/(x+y)≤1.26; and when M is Sr, Ba, or Co then 0.45≤x/(x+y)≤0.55 and 1.35≤z/(x+y)≤1.65; and when M is Zn, or Mg then 0.30≤x/(x+y)≤0.37 and 1.20≤z/(x+y)≤1.47. 14 . The system of claim 13 , wherein at least one of the one or more components is represented by M x Mn y O z ; and M x Mn y O z is in an orthorhombic phase when M represents Ca and 0.45≤x/(x+y)≤0.55 or when M represents Sr; M x Mn y O z is in a cubic phase when M represents Ni and 0.77≤x/(x+y)≤0.99; M x Mn y O z is in a trigonal phase when M represents Ni and 0.45≤x/(x+y)≤0.55 or when M represent Co; M x Mn y O z is in a tetragonal phase when M represents Zn or Mg; M x Mn y O z is in a hexagonal phase when M represents Ba; and M x Mn y O z is in a monoclinic phase when M represents Ca and 1.35≤z/(x+y)≤1.65. 15 . The system of claim 13 , wherein the one or more components are selected from the group consisting of CaMnO 3 in the orthorhombic phase, NiMnO 3 in the trigonal phase, SrMnO 3 in the orthorhombic phase, ZnMn 2 O 4 in the tetragonal phase, MgMn 2 O 4 in the tetragonal phase, Ni 6 MnO 8 in the cubic phase, BaMnO 3 in the hexagonal phase, CoMnO 3 in the trigonal phase, and Ca 2 Mn 3 O 8 in the monoclinic phase. 16 . The system of claim 13 , wherein the anode excludes an Oxygen Evolution Reaction catalyst in addition to the one or more components. 17 . The system of claim 13 , wherein the anode contacts an anolyte having a pH less than 3. 18 . The system of claim 13 , further comprising: a bias source that applies a bias at or below 1.23 V vs RHE to the anode during operation of the system so as to generate oxygen. 19 . The system of claim 13 , wherein the one or more components absorb light and convert the absorbed light into excited electron-hole pairs during operation of the system so as to generate oxygen. 20 . The system of claim 13 , wherein the one or more components catalyze the oxygen evolution reaction during operation of the system so as to generate oxygen.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018305831A1 cover?
An oxygen evolution reaction catalyst is a ternary metal oxide that includes Mn and is represented by Mn u Sb v O w in the rutile crystal phase and M x Mn y O z where M is selected from the group consisting of Ca, Ni, Sr, Zn, Mg, Ni, Ba, Co and where u/(u+v) is greater than 33%.
Who is the assignee on this patent?
California Inst Of Techn
What technology area does this patent fall under?
Primary CPC classification C02F1/46109. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).